Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P Select Sector Capped 20% Health Care |
| Investment focus | Equity, United States, Health Care |
| Fund size | GBP 300 m |
| Total expense ratio | 0.14% p.a. |
| Replication | Synthetic (Unfunded swap) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 17.89% |
| Inception/ Listing Date | 16 December 2009 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Invesco |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | Northern Trust International Fund Administration Services (Ireland) Limited |
| Investment Advisor | Invesco Capital Management LLC |
| Custodian Bank | Northern Trust Fiduciary Services (Ireland) Limited |
| Revision Company | PricewaterhouseCoopers |
| Fiscal Year End | 30 November |
| Swiss representative | BNP Paribas, Paris, succursale de Zurich |
| Swiss paying agent | BNP Paribas, Paris, succursale de Zurich |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | BofA Merrill Lynch|Goldman Sachs|J.P. Morgan|Morgan Stanley|Nomura |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| YTD | +6.03% |
| 1 month | +3.21% |
| 3 months | +13.06% |
| 6 months | +18.30% |
| 1 year | +2.53% |
| 3 years | +6.53% |
| 5 years | +47.12% |
| Since inception (MAX) | +614.00% |
| 2024 | +3.70% |
| 2023 | -3.86% |
| 2022 | +9.47% |
| 2021 | +27.25% |
| Volatility 1 year | 17.89% |
| Volatility 3 years | 14.96% |
| Volatility 5 years | 15.98% |
| Return per risk 1 year | 0.14 |
| Return per risk 3 years | 0.14 |
| Return per risk 5 years | 0.50 |
| Maximum drawdown 1 year | -19.26% |
| Maximum drawdown 3 years | -19.26% |
| Maximum drawdown 5 years | -19.26% |
| Maximum drawdown since inception | -19.80% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| London Stock Exchange | GBX | XLVP | - - | - - | - |
| gettex | EUR | SML4 | - - | - - | - |
| Borsa Italiana | EUR | XLVS | XLVS IM XLVSIN | XLVS.MI XLVSINAV.DE | Banca IMI Commerzbank Flow Traders Susquehanna UniCredit |
| London Stock Exchange | USD | XLVS | XLVS LN XLVSIN | XLVS.L XLVSINAV.DE | Banca IMI Commerzbank Flow Traders Susquehanna UniCredit |
| London Stock Exchange | GBP | - | XLVP LN XLVSIN | XLVP.L XLVSINAV.DE | Banca IMI Commerzbank Flow Traders Susquehanna UniCredit |
| SIX Swiss Exchange | USD | XLVS | XLVS SW XLVSIN | XLVS.S XLVSINAV.DE | Banca IMI Commerzbank Flow Traders Susquehanna UniCredit |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares S&P 500 Health Care Sector UCITS ETF (Acc) | 2,282 | 0.15% p.a. | Accumulating | Full replication |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 999 | 0.12% p.a. | Distributing | Full replication |
| iShares Nasdaq US Biotechnology UCITS ETF | 715 | 0.35% p.a. | Accumulating | Sampling |
| SPDR S&P U.S. Health Care Select Sector UCITS ETF USD | 448 | 0.15% p.a. | Accumulating | Full replication |
| Invesco Nasdaq Biotech UCITS ETF | 375 | 0.40% p.a. | Accumulating | Swap-based |